Law­mak­ers call for 'line in the sand' be­tween US and Chi­nese biotech com­pa­nies

De­moc­rats and Re­pub­li­cans on the House Se­lect Com­mit­tee on the Chi­nese Com­mu­nist Par­ty railed against Chi­nese biotech com­pa­nies in a Thurs­day hear­ing on na­tion­al se­cu­ri­ty, call­ing for a “line in the sand” be­tween the US and “for­eign ad­ver­sary” com­pa­nies.

The hear­ing comes as a group of bi­par­ti­san law­mak­ers push for a se­ries of con­tentious bills that would re­strict re­la­tions with some for­eign com­pa­nies like re­search and man­u­fac­tur­ing con­trac­tor WuXi AppTec and ge­nomics gi­ant BGI Group. Com­mit­tee Chair Mike Gal­lagher (R-WI) and rank­ing mem­ber Ra­ja Kr­ish­namoor­thi (D-IL) in­tro­duced leg­is­la­tion in Jan­u­ary that would ban fed­er­al­ly fund­ed en­ti­ties from do­ing busi­ness with so-called “com­pa­nies of con­cern.” But on Thurs­day, Kr­ish­namoor­thi said law­mak­ers “need to do even more.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER